‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options
Health insurers issue millions of prior authorization denials every year, leaving many patients stuck in a convoluted appeals process, with
NEWS Online - Health
Read More »
Jenna Ryu
19:20
Submit Your Questions for ‘Asking for a Friend,’ SELF’s New Friendship Column
Therapist Miriam Kirmayer is here to help you make sense of your messiest, most complicated friendship moments...
Tife Oni
15:21
The #NairaLife of a Medical Student Who Doesn’t See a Future in Medicine
As a teenager, the 24-year-old in this #NairaLife found an income opportunity writing on Facebook. Now, as a medical student,
Nancie Haslett
20:21
‘Was hoping for a rank below 200’: NEET 2025 surprises 6 Karnataka toppers with “dream” ranks
Despite a challenging NEET 2025, several Karnataka students achieved remarkable ranks. Ruchir Gupta (AIR 22) fulfilled his mother's dream, while
Elroy Mcnaught
16:20
These Supplements Promise Larger Loads—But Are They Safe? What Urologists Want You to Know.
Think those load-boosting supplements will turn you into a porn star? Read this before you swallow the hype...
Elroy Roberie
16:20
The 11 Best Running Shorts for Men in 2025, Tested by Running Experts
Every mile feels a little better in a comfortable, stylish pair of shorts...
Elroy Wrona
16:20
Carrie Anne-Moss Goes Toe-to-Toe With Arnold Schwarzenegger as Greta Nelso in FUBAR Season 2
Has Arnold met his match...
Luz Lanz
14:21
Gut Bugs and Respiratory Illness in Children; Heat Illness and Homelessness
MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for
Johnathon Noren
10:20
Neighborly help in the brain: Cerebral cortex networks rapidly reorganize to compensate for lost neurons
How the brain largely maintains its function when neurons are lost—this is what researchers at the University Medical Center Mainz,
Georgianna Damron
10:20
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of
